Lilly’s obesity pill helps reduce cardiovascular risks in late-stage trial

In the study of more than 2,700 adults, patients taking Foundayo had a 16% lower risk of heart attack, stroke or cardiovascular death.

Leave a Reply

Your email address will not be published. Required fields are marked *